{"organizations": [], "uuid": "ec48a064517b6fd428f2d4bcb711380401e14538", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180123.html", "section_title": "Archive News &amp; Video for Tuesday, 23 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-genmab-2017-net-sales-of-darzalex/brief-genmab-2017-net-sales-of-darzalex-at-1-24-billion-idUSASM000IEI", "country": "US", "domain_rank": 408, "title": "BRIEF-Genmab 2017 Net Sales Of DARZALEX At $1.24 Billion", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.282, "site_type": "news", "published": "2018-01-23T19:56:00.000+02:00", "replies_count": 0, "uuid": "ec48a064517b6fd428f2d4bcb711380401e14538"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-genmab-2017-net-sales-of-darzalex/brief-genmab-2017-net-sales-of-darzalex-at-1-24-billion-idUSASM000IEI", "ord_in_thread": 0, "title": "BRIEF-Genmab 2017 Net Sales Of DARZALEX At $1.24 Billion", "locations": [], "entities": {"persons": [{"name": "genmab", "sentiment": "negative"}, {"name": "johnson", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 23 (Reuters) - GENMAB:\n* ANNOUNCES 2017 NET SALES FIGURES FOR DARZALEX® (DARATUMUMAB)\n* ‍WORLDWIDE NET SALES OF DARZALEX (DARATUMUMAB) AS REPORTED BY JOHNSON & JOHNSON WERE USD 1,242 MILLION IN 2017​\n* ‍NET SALES WERE USD 884 MILLION IN U.S. AND NET SALES IN REST OF WORLD WERE USD 358 MILLION​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-23T19:56:00.000+02:00", "crawled": "2018-01-24T15:36:26.023+02:00", "highlightTitle": ""}